Psoriasis: neuer IL-17-Antikörper zugelassen
Crossref DOI link: https://doi.org/10.1007/s15012-017-2536-1
Published Online: 2017-09-16
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sankawa, Yuri